CAS Key Laboratory of Protein and Peptide Pharmaceuticals, IBP CAS
中国科学院生物物理研究所蛋白质与多肽药物所重点实验室
China
1 August 2019 - 31 July 2020
Principal institution: Institute of Biophysics (IBP), CAS
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for CAS Key Laboratory of Protein and Peptide Pharmaceuticals, IBP CAS published between 1 August 2019 - 31 July 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 9 | 1.70 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 5 | 1.19 | |
| Chemistry | 4 | 0.51 | |
| Physical Sciences | 2 | 0.36 | |
Top articles by Altmetric score in current window
A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8 T-cell response and effective tumor control
Nature Communications
2019-08-28
Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B
Nature Nanotechnology
2020-03-02
CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension
Nature Communications
2019-08-07
Interplay between the bacterial protein deacetylase CobB and the second messenger c‐di‐
GMP
The EMBO Journal
2019-08-16
Fenozyme Protects the Integrity of the Blood–Brain Barrier against Experimental Cerebral Malaria
Nano Letters
2019-11-06
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
